CD33 and leukemia: The single-chain Fv trisomics (sctb) based on CD16 single-chain Fv fragment (scFv) targeting CD123 exhibits significant anti-leukemia activity, but its effect is not as good as the dual-targeting sctb targeting both CD33 and CD123 (79).